FDA Inspection 1210838 — Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd
The FDA completed an inspection of Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd on June 16, 2023 in Gao Xiong Shi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gao Xiong Shi (Taiwan)